Skip to main content
Clinical Trials/CTRI/2024/03/063717
CTRI/2024/03/063717
Not yet recruiting
未知

Incidence of residual neuromuscular blockade In post anaesthesia care unit after elective onco-surgeries: a prospective observational study. - nil

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: C00-D49- Neoplasms
Sponsor
Tata Memorial Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. ASA 1\-3 adult patients undergoing elective onco\-surgery under general anesthesia receiving non depolarizing muscle relaxants in the main OT (operation theatre) complex

Exclusion Criteria

  • 1\.Patient refusal
  • 2\.Age less than 18 years
  • 3\.Pregnant patients
  • 4\.Pre existing neuromuscular disease
  • 5\.Patients undergoing Neurosurgeries
  • 6\.Patients shifted to PACU on mechanical ventilation
  • 7\.Patients getting shifted to any other area than the recovery unit situated in the main OT complex.
  • 8\.Emergency surgeries and surgeries done on weekends

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Occurance of residual neuromuscular blockade in patients received general anesthesiaDiseases which need operation under general anesthesia
JPRN-UMIN0000026394 University investigation of neuromuscular blockade25
Active, not recruiting
Not Applicable
Investigation on occurence of muscle weakness after surgeriesThe effect of sugammadex and neostigmin on postoperative residual neuromuscular blockade will be investigated, therefore the patients suffering from various conditions undergoing surgery in general anaesthesia with muscle relaxation will be included int he study.sthesia with muscle relaxation will be included in the study.MedDRA version: 16.0Level: PTClassification code 10057286Term: Neuromuscular blockade reversalSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Physiological processes [G07]
EUCTR2013-001965-17-HUDebreceni Egyetem Orvos- és Egészségtudományi Centrum Aneszteziológiai és Intenzív Terápiás Tanszék
Completed
Not Applicable
Prevention of residual neuromuscular blockade with sugammadex in patients received general anesthesia
JPRN-UMIN000004522Tokyo Neuromuscular Meeting25
Completed
Not Applicable
The effects of deep neuromuscular blockade during robot-assisted transaxillary thyroidectomy on postoperative pain and sensory change; prospective randomized control trialNeoplasms
KCT0003565Yonsei University Health System, Severance Hospital88
Completed
Not Applicable
Prolonging muscle paralysis after surgery: a comparative age-matched studyPost-operative residual neuromuscular blockadeNervous System Diseases
ISRCTN14366665First Affiliated Hospital of Dalian Medical University237